on Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ)
Eckert & Ziegler and UJF Boost Actinium-225 Production
Eckert & Ziegler SE and the Nuclear Physics Institute of the Czech Academy of Sciences have significantly increased the production volume of Actinium-225, transitioning to large-scale manufacturing in Řež and Braunschweig. This development positions Eckert & Ziegler among the few global suppliers capable of providing sufficient quantities of this crucial radioisotope.
Actinium-225 is highly sought after for targeted radiopharmaceutical applications, particularly in treating small tumors and micrometastases. However, production has been limited due to complex technical challenges. The expanded capacity is a strategic milestone that promises to improve global supply and foster advancement in diagnostics and therapeutics.
Eckert & Ziegler supplies other critical isotopes like Gallium-68 and Lutetium-177, enhancing their commitment to supporting innovative radiopharmaceutical developments.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news